Preoperative high dose rate brachytherapy for rectal cancer
Guidance issued
Number: IPG201
Summary:
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on preoperative high dose rate brachytherapy for rectal cancer.
Description:
Rectal cancer is a common form of bowel cancer. Preoperative high dose rate brachytherapy involves placing radioactive material in or close to the tumour to shrink it before surgery.
Arrangement:
Other (see guidance)
Topic Area:
Cancer
Digestive system
Specialty:
Clinical oncology
Gastroenterology
Medical oncology
Specialist advice has been sought from:
Royal College of Radiologists
Association of Coloproctology of Great Britain and Ireland
Date notified to NICE:
12 August 2005
Provisional consultation date:
Summer 2006
IP Pub Date:
13 December 2006
Contact
Details:
Project manager (for general enquiries or comments)
(for general enquiries or comments)
